Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEFLAZACORT TABLETS safely and effectively. See full prescribing information for DEFLAZACORT TABLETS . DEFLAZACORT tablets, for oral use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Additional pediatric use information is approved for PTC Therapeutics, Inc.'s Emflaza™ (deflazacort) tablets. However, due to PTC Therapeutics, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information.
- generic_name
- deflazacort
- product_names
- deflazacort
- ndc
- 60219-2282, 60219-2283, 60219-2284, 60219-2285, 60219-2282-1, 60219-2283-1, 60219-2284-1, 60219-2285-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en